AWAKN LIFE SCIENCES CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.175 CAD | -20.45% |
|
-2.78% | +20.69% |
Chart calendar Awakn Life Sciences Corp.
e074fa269cb2.Kw9fo4DHjDdXYWbusbPdghwR0qx8WYTa6QnpiSzecZ0.eTwM5Ouu1FEGDxPcx9iq9FBgkehFHLfv0WCC0RquGehSQQfA0PP5Zh4uCQ~cf1cd9c4ac139abec7201fc8aef70e56
Upcoming events on Awakn Life Sciences Corp.
Past events on Awakn Life Sciences Corp.
| 2024-04-24 | Q4 2023 Earnings Release (Projected) |
| 2023-12-14 05:47 pm | Q3 2023 Earnings Release |
| 2023-09-14 07:21 am | Q2 2023 Earnings Release |
| 2023-06-27 10:00 am | Annual General Meeting |
| 2023-06-22 09:00 am | Maxim Group Virtual Healthcare Conference |
| 2023-06-14 06:03 pm | Q1 2023 Earnings Release |
| 2023-04-27 05:06 pm | Q4 2022 Earnings Release |
| 2022-12-15 07:30 am | Q3 2022 Earnings Release |
| 2022-09-14 06:54 pm | Interim 2022 Earnings Release |
| 2022-06-27 07:00 am | H.C. Wainwright Mental Healthcare Conference |
| 2022-06-22 10:00 am | Emerging Growth Conference |
| 2022-06-14 05:06 pm | Q1 2022 Earnings Release |
| 2022-05-28 07:30 pm | FromResearch to Reality Global Summit on Psychedelic-Assisted Therapies and Medicine Conference - Pa |
| 2022-05-27 05:30 pm | FromResearch to Reality Global Summit on Psychedelic-Assisted Therapies and Medicine Conference - Pa |
| 2022-05-27 08:45 am | FromResearch to Reality Global Summit on Psychedelic-Assisted Therapies and Medicine Conference - Pa |
| 2022-05-26 04:30 pm | Investor Hotseat Conference |
| 2022-05-24 07:00 am | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-19 08:30 am | Nordic Psychedelic Science Conference |
| 2022-05-11 11:30 am | PSYCH Symposium - Panel |
| 2022-05-11 05:40 am | PSYCH Symposium |
Annual results
| Fiscal Period | January | 2022 | 2023 |
|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,24 0,15 53.77% | 1,50 1,58 -5.36% |
|
EBITDA Million CAD | Released Forecast Spread | -8,52 -8,54 0.15% | -7,96 -7,58 -5.07% |
|
EBIT Million CAD | Released Forecast Spread | -9,79 -9,32 -5.05% | -9,19 -8,74 -5.12% |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
|
Net income Million CAD | Released Forecast Spread | -15,9 -15,8 -1.08% | -9,14 -8,73 -4.77% |
|
EPS CAD | Released Forecast Spread | -0,73 -0,72 -1.39% | -0,36 -0,31 -16.13% |
| Announcement Date | 28/04/22 | 27/04/23 |
Quarterly results
| Fiscal Period | Januar | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,20 0,14 48.04% | 0,25 0,34 -24.88% | 0,34 0,62 -45.14% | 0,43 0,30 43.5% | 0,47 0,56 -15.29% | 0,51 0,69 -25.87% | 0,00 | |
|
EBITDA Million CAD | Released Forecast Spread | -3,55 -3,15 -12.7% | -2,51 -4,11 38.96% | -2,01 -2,58 22.04% | -1,66 -2,89 42.62% | -1,98 -1,60 -24.06% | -1,78 -1,54 -15.64% | -1,46 -0,84 -73.31% | |
|
EBIT Million CAD | Released Forecast Spread | -3,96 -3,50 -12.91% | -2,65 -4,20 36.97% | -2,31 -3,42 32.51% | -1,88 -2,90 35.08% | -2,35 -1,91 -23.45% | -1,95 -1,89 -3.39% | -1,46 -1,17 -25.04% | |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -4,18 -3,61 -15.8% | -2,80 -4,20 33.31% | -2,39 -3,43 30.34% | -1,62 -2,90 44.03% | -2,84 -1,91 -48.34% | -1,68 -1,89 11.29% | -1,15 -1,18 2.26% | |
|
Net income Million CAD | Released Forecast Spread | -2,95 | -4,04 -3,61 -11.99% | -2,72 -4,20 35.3% | -2,30 -3,43 32.94% | -1,47 -2,90 49.28% | -2,66 -1,91 -38.73% | -1,68 -1,89 11.29% | -1,75 -1,18 -48.57% |
|
EPS CAD | Released Forecast Spread | -0,16 -0,15 -6.67% | -0,11 -0,15 26.67% | -0,09 -0,08 -12.5% | -0,05 -0,08 37.5% | -0,09 -0,06 -50% | -0,06 -0,05 -20% | -0,06 -0,04 -50% | |
| Announcement Date | 15/12/21 | 28/04/22 | 14/06/22 | 14/09/22 | 15/12/22 | 27/04/23 | 14/06/23 | 14/09/23 |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Awakn Life Sciences Corp.
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-29 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-28 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-28 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 2024-04-28 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-28 | MORPHOSYS AG: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AWKN Stock
- Calendar Awakn Life Sciences Corp.
